Women's attitudes towards disclosure of genetic information in pregnancy with varying levels of penetrance

• DOI: 10.1002/pd.6518
• Publication Date: 2024-01-15T05:20:05Z
• Authors: Vitalia Libman; Michal Macarov; Yechiel Friedlander; Drorith Hochner‐C...; Yishai Sompolinsky; Uri P. Dior; Michael Osovsky; Lina Basel‐Salmon; Arnon Wiznitzer; Yehuda Neumark; Vardiella Meiner; Ayala Frumkin; Hagit Hochner; Shiri Shkedi‐Rafid
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Pregnancy; Prenatal Diagnosis; Uncertainty; Humans; Female; Penetrance; Prenatal Care; Disclosure

AbstractBackgroundChromosomal‐microarray‐analysis (CMA) may reveal susceptibility‐loci (SL) of varied penetrance for autism‐spectrum‐disorder (ASD) and other neurodevelopmental conditions. Attitudes of women/parents to disclosure of SL during pregnancy are understudied.MethodsA multiple‐choice questionnaire was distributed to postpartum women. Data were collected on women's interest to receive prenatal genetic information with various levels of penetrance.ResultsWomen's (n = 941) disclosure choices were dependent on the magnitude of risk: approximately 70% supported disclosure of either full or 40% penetrance, 53% supported disclosure at a 20% risk threshold, and 40% supported disclosure at 10% or less. Although most women supported, rejected or were indecisive about disclosure consistently across all risk levels, nearly one‐quarter (24%) varied their responses based on penetrance, and this was associated with religiosity, education, parity and concern about fetal health (p‐values <0.04). Among those who varied their choices, the risk threshold was lower among secular women (20%) than among ultraorthodox women (40%). In a multivariable analysis, ultraorthodox women were much less likely to vary their choices on ASD disclosure compared with secular women (aOR = 0.37, p < 0.001).ConclusionWomen's attitudes toward disclosure are influenced by the level of risk and their individual characteristics. We therefore encourage engaging women/couples in disclosure decisions regarding uncertain and probabilistic results from prenatal genomic tests.